Literature DB >> 23253778

Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease.

Paula T Trzepacz1, Peng Yu, Phani K Bhamidipati, Brian Willis, Tammy Forrester, Linda Tabas, Adam J Schwarz, Andrew J Saykin.   

Abstract

BACKGROUND: The neuroanatomy of agitation and aggression in Alzheimer's disease is not well understood.
METHODS: We analyzed 24 months of Alzheimer's Disease Neuroimaging Initiative data for patients with Alzheimer's disease, mild cognitive impairment-stable, and mild cognitive impairment-converter (n = 462) using the Neuropsychiatric Inventory Questionnaire Agitation and Aggression subscale. Magnetic resonance imaging regions of interest that correlated with Neuropsychiatric Inventory Questionnaire Agitation and Aggression subscale raw scores were included in mixed-model, repeated-measures analyses of agitation and aggression over time with age, sex, apolipoprotein E ε4 status, education, and Mini-Mental State Examination score as covariates.
RESULTS: Neuropsychiatric Inventory Questionnaire Agitation and Aggression subscale scores worsened in patients with Alzheimer's disease and in mild cognitive impairment-converter (P < .05; trend for mild cognitive impairment, P = .0518). Greater agitation and aggression severity was associated with greater atrophy of frontal, insular, amygdala, cingulate, and hippocampal regions of interest (P < .05). Mini-Mental State Examination score was significant in mixed-effect model repeated measures only in mild cognitive impairment-converters for posterior regions of interest. Demographics and apolipoprotein ε4 were not associated with agitation and aggression.
CONCLUSIONS: Agitation and aggression in Alzheimer's disease and mild cognitive impairment is associated with neurodegeneration affecting the anterior salience network that may reduce capacity to process and regulate behaviors properly.
Copyright © 2013 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Agitation and aggression; Alzheimer's disease; Frontolimbic; MRI; Mild cognitive impairment; Salience network

Mesh:

Year:  2012        PMID: 23253778      PMCID: PMC3955297          DOI: 10.1016/j.jalz.2012.10.005

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  49 in total

1.  The course of neuropsychiatric symptoms in dementia. Part I: findings from the two-year longitudinal Maasbed study.

Authors:  Pauline Aalten; Marjolein E de Vugt; Niek Jaspers; Jaspers Jolles; Frans R J Verhey
Journal:  Int J Geriatr Psychiatry       Date:  2005-06       Impact factor: 3.485

2.  Diffusion anisotropy and diffusivity of white matter tracts within the temporal stem in Alzheimer disease: evaluation of the "tract of interest" by diffusion tensor tractography.

Authors:  T Taoka; S Iwasaki; M Sakamoto; H Nakagawa; A Fukusumi; K Myochin; S Hirohashi; T Hoshida; K Kichikawa
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

3.  A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease.

Authors:  David Craig; Ajay Mirakhur; Dominic J Hart; Stephen P McIlroy; A Peter Passmore
Journal:  Am J Geriatr Psychiatry       Date:  2005-06       Impact factor: 4.105

4.  Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease.

Authors:  S Tekin; M S Mega; D M Masterman; T Chow; J Garakian; H V Vinters; J L Cummings
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

5.  Derivation of a brief measure of agitation and aggression in Alzheimer's disease.

Authors:  Ellen B Dennehy; Kristin Kahle-Wrobleski; Khaled Sarsour; Denái R Milton
Journal:  Int J Geriatr Psychiatry       Date:  2012-04-18       Impact factor: 3.485

6.  Left frontotemporal hypoperfusion is associated with aggression in patients with dementia.

Authors:  N Hirono; M S Mega; I D Dinov; F Mishkin; J L Cummings
Journal:  Arch Neurol       Date:  2000-06

7.  Von Economo neurons are present in the dorsolateral (dysgranular) prefrontal cortex of humans.

Authors:  C Fajardo; M I Escobar; E Buriticá; G Arteaga; J Umbarila; M F Casanova; H Pimienta
Journal:  Neurosci Lett       Date:  2008-03-04       Impact factor: 3.046

8.  Apolipoprotein epsilon4 status is associated with behavioral symptoms in nursing home residents with dementia.

Authors:  Diana Lynn Woods; Brittany Bushnell; Haesook Kim; Daniel Geschwind; Jeffrey Cummings
Journal:  Int Psychogeriatr       Date:  2009-05-27       Impact factor: 3.878

9.  Diffusion abnormalities of the uncinate fasciculus in Alzheimer's disease: diffusion tensor tract-specific analysis using a new method to measure the core of the tract.

Authors:  Hasina Yasmin; Yasuhiro Nakata; Shigeki Aoki; Osamu Abe; Noriko Sato; Kiyotaka Nemoto; Kunimasa Arima; Nobuo Furuta; Masatake Uno; Shigeo Hirai; Yoshitaka Masutani; Kuni Ohtomo
Journal:  Neuroradiology       Date:  2008-02-02       Impact factor: 2.804

10.  Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia.

Authors:  Federica Agosta; Keith A Vossel; Bruce L Miller; Raffaella Migliaccio; Stephen J Bonasera; Massimo Filippi; Adam L Boxer; Anna Karydas; Katherine L Possin; Maria Luisa Gorno-Tempini
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-22       Impact factor: 11.205

View more
  35 in total

Review 1.  Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?

Authors:  Paul B Rosenberg; Milap A Nowrangi; Constantine G Lyketsos
Journal:  Mol Aspects Med       Date:  2015-06-03

Review 2.  Cannabinoids for Agitation in Alzheimer's Disease.

Authors:  John D Outen; M Haroon Burhanullah; Ryan Vandrey; Halima Amjad; David G Harper; Regan E Patrick; Rose L May; Marc E Agronin; Brent P Forester; Paul B Rosenberg
Journal:  Am J Geriatr Psychiatry       Date:  2021-01-27       Impact factor: 4.105

Review 3.  2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2015-06       Impact factor: 21.566

4.  Brainstem reflexes are hyperactive in patients with drug-induced akathisia.

Authors:  Baris Metin; Sinem Zeynep Metin; Aysegul Gunduz; Burc Cagri Poyraz; Mine Ozmen; Gunes Kiziltan; Meral E Kiziltan
Journal:  Neurol Sci       Date:  2017-07-05       Impact factor: 3.307

5.  Is bigger better? Towards a mechanistic understanding of neuropsychiatric symptoms in Alzheimer's disease.

Authors:  Milap A Nowrangi; Paul B Rosenberg
Journal:  Int Psychogeriatr       Date:  2021-09-24       Impact factor: 3.878

6.  Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.

Authors:  Stéphane P Poulin; David Bergeron; Bradford C Dickerson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  Personality Changes During the Transition from Cognitive Health to Mild Cognitive Impairment.

Authors:  Richard J Caselli; Blake T Langlais; Amylou C Dueck; Bruce R Henslin; Travis A Johnson; Bryan K Woodruff; Charlene Hoffman-Snyder; Dona E C Locke
Journal:  J Am Geriatr Soc       Date:  2018-01-17       Impact factor: 5.562

8.  The Relationship Between Anxiety and Incident Agitation in Alzheimer's Disease.

Authors:  Kathy Y Liu; Harry Costello; Suzanne Reeves; Robert Howard
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

9.  Examining differences in neuropsychiatric symptom factor trajectories in empirically derived mild cognitive impairment subtypes.

Authors:  Alyssa N De Vito; Matthew Calamia; Daniel S Weitzner; John P K Bernstein
Journal:  Int J Geriatr Psychiatry       Date:  2018-10-01       Impact factor: 3.485

Review 10.  Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: a systematic review of symptom-general and -specific lesion patterns.

Authors:  Yaojing Chen; Mingxi Dang; Zhanjun Zhang
Journal:  Mol Neurodegener       Date:  2021-06-07       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.